Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo
Noémie Cresto, Marie‐Claude Gaillard, Camille Gardier, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104614-104614
Open Access | Times Cited: 18

Showing 18 citing articles:

Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 91
Advances in animal models of Parkinson's disease
He Sui, Qin Ru, Lin Chen, et al.
Brain Research Bulletin (2024) Vol. 215, pp. 111024-111024
Open Access | Times Cited: 8
Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain
Ana Lúcia Rebelo, Francesco Gubinelli, Pauline Roost, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 34
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 29
Genetically modified macrophages accelerate myelin repair
Marie‐Stéphane Aigrot, Clara Barthelemy, Sarah Moyon, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 18
Gene-modified animal models of Parkinson's disease
Yong Peng, Dazhi Jiang, Shunyu Yao, et al.
Experimental Neurology (2025) Vol. 390, pp. 115287-115287
Closed Access
Long noncoding RNA CYTOR triggers gastric cancer progression by targeting miR-103/RAB10
Fang Wei, Yong Wang, Yong Zhou, et al.
Acta Biochimica et Biophysica Sinica (2021) Vol. 53, Iss. 8, pp. 1044-1054
Closed Access | Times Cited: 21
Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses
Ana Fajardo‐Serrano, Alberto J. Rico, Elvira Roda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 20
Molecular Pathways Involved in LRRK2-Linked Parkinson’s Disease: A Systematic Review
Ailyn Irvita Ravinther, Hemaniswarri Dewi Dewadas, Shi Ruo Tong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11744-11744
Open Access | Times Cited: 14
LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons
Olga Skiteva, Ning Yao, Giacomo Sitzia, et al.
Journal of Neurochemistry (2022) Vol. 161, Iss. 2, pp. 158-172
Open Access | Times Cited: 13
Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests
Francesco Gubinelli, G. Cazzolla, Matilde Negrini, et al.
Behavioural Brain Research (2022) Vol. 429, pp. 113887-113887
Open Access | Times Cited: 9
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo
Noémie Cresto, Camille Gardier, Marie‐Claude Gaillard, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6760-6760
Open Access | Times Cited: 10
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Chutian Zhang, Shiya Chen, Xiyu Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113768-113768
Open Access | Times Cited: 7
14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity and toxicity
Rudradip Pattanayak, Roschongporn Ekkatine, Chad M. Petit, et al.
Human Molecular Genetics (2024)
Closed Access | Times Cited: 1
14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity
Rudradip Pattanayak, Chad M. Petit, Talene A. Yacoubian
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Multi-method computational evaluation of the inhibitors against leucine-rich repeat kinase 2 G2019S mutant for Parkinson's disease
Ahmed Elhadi, Dan Zhao, Noman Ali, et al.
Molecular Diversity (2024)
Open Access
Translational View on Therapeutic Strategies and Upcoming Issues: Stem Cell and Brain Organoid Approaches for Parkinson’s Disease Therapy
Francesco Gubinelli, Jose M. Salazar, Janina Kaspar, et al.
Neuromethods (2024), pp. 241-275
Closed Access
Multi-method computational evaluation of the inhibitors against leucine-rich repeat kinase 2 G2019S mutant for Parkinson's disease
Ahmed Elhadi, Dan Zhao, Noman Ali, et al.
Research Square (Research Square) (2023)
Open Access
Genetically-Modified Macrophages Accelerate Myelin Repair
Marie‐Stéphane Aigrot, Clara Barthelemy, Sarah Moyon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top